纤维蛋白溶解酶治疗急性脑梗死临床疗效观察

Clinical observations on the therapeutic effect of fibrinolysis Saibai in treatment of acute cerebral infarction

目的观察注射用纤维蛋白溶解酶(商品名赛百()治疗急性脑梗死的疗效。方法采用赛百(治疗44例起病72h内的脑梗死患者,根据统一制定的卒中患者临床神经功能缺损程度评分标准评定治疗效果。结果赛百(治疗急性脑梗死显著进步10例(22.7%),进步25例(56.8%),总有效率为79.5%,且对出血时间、凝血时间、凝血酶原时间无显著影响(P>0.05)。结论赛百(为治疗急性脑梗死有效和安全的药物。

Objective To make observations on the effect of Fibrinolysis （Saibai） in treatment of acute cerebral infarction. Methods To treated and observed on 44 cases of cerebral infarction which occurred within 72 hours ;according to ＂the standard mark of function clinical nervous defect with apoplexy＂, to evaluated the curative effect which was managed statistically. Results Saibai had significant affect in treating acute cerebral infarction. 10 cases （22. 7%） of cerebral infarction relieved greatly and 25 cases （56. 8%） improved, the overall effective rate accounted for 79. 5%. Conclusion These results suggested that fibrinolysis Saibai is an effective and safe drug in treatment of acute cerebral infarction.